v3.26.3
SCHEDULE OF DISAGGREGATED REVENUE (Details) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2026
Sep. 30, 2025
Sep. 30, 2026
Sep. 30, 2025
Disaggregation of Revenue [Line Items]        
Total net revenue $ 44,625,086 $ 47,727,942 $ 142,048,848 $ 146,861,697
Total net revenue, percent 100.00% 100.00% 100.00% 100.00%
Telehealth Subscription Revenue [Member]        
Disaggregation of Revenue [Line Items]        
Total net revenue $ 27,714,009 $ 27,748,440 $ 87,379,901 $ 86,127,426
Total net revenue, percent 62.00% 58.00% 62.00% 59.00%
Telehealth [Member]        
Disaggregation of Revenue [Line Items]        
Total net revenue $ 16,828,707 $ 19,979,502 $ 54,586,577 $ 60,734,271
Total net revenue, percent 38.00% 42.00% 38.00% 41.00%
Telehealth Service Fee [Member]        
Disaggregation of Revenue [Line Items]        
Total net revenue [1] $ 82,370 $ 82,370
Total net revenue, percent [1] 0.00% 0.00%
[1] Telehealth service fee revenue primarily relates to data reporting fees charged by the Company in connection with the fulfillment of orders for the Company’s pharmaceutical supply agreements.